ZA777532B - 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same - Google Patents

1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same

Info

Publication number
ZA777532B
ZA777532B ZA00777532A ZA777532A ZA777532B ZA 777532 B ZA777532 B ZA 777532B ZA 00777532 A ZA00777532 A ZA 00777532A ZA 777532 A ZA777532 A ZA 777532A ZA 777532 B ZA777532 B ZA 777532B
Authority
ZA
South Africa
Prior art keywords
preparation
same
pharmaceutical composition
dihydropyridine compounds
dihydropyridine
Prior art date
Application number
ZA00777532A
Other languages
English (en)
Inventor
Y Sato
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA777532B publication Critical patent/ZA777532B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00777532A 1976-12-17 1977-12-19 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same ZA777532B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52720/76A GB1591089A (en) 1976-12-17 1976-12-17 1,4-dihydropyridine derivatives and process for preparation thereof

Publications (1)

Publication Number Publication Date
ZA777532B true ZA777532B (en) 1978-10-25

Family

ID=10465031

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00777532A ZA777532B (en) 1976-12-17 1977-12-19 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same

Country Status (15)

Country Link
JP (1) JPS5948828B2 (de)
AR (2) AR221478A1 (de)
AT (1) AT367401B (de)
AU (1) AU518206B2 (de)
BE (1) BE861964A (de)
CH (1) CH633266A5 (de)
DE (1) DE2756226A1 (de)
DK (2) DK563377A (de)
ES (3) ES465137A1 (de)
FR (1) FR2374307A1 (de)
GB (1) GB1591089A (de)
HU (1) HU176454B (de)
NL (1) NL7714066A (de)
SE (2) SE7714374L (de)
ZA (1) ZA777532B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS57175164A (en) * 1981-04-18 1982-10-28 Banyu Pharmaceut Co Ltd 1,4-dihydropyridine derivative and its preparation
EP0080220B1 (de) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridine, Verfahren zu ihrer Herstellung, ihre Zusammensetzungen und ihre Verwendung als Arzneimittel
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
EP0226271B1 (de) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-Dihydropyridinverbindungen und ihre Herstellung und pharmazeutische Formulierung
DE3544211A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
FR2596760B1 (fr) * 1986-04-02 1988-12-09 Sori Soc Rech Ind Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd ２位置換１，４−ジヒドロピリジン誘導体
US5977369A (en) * 1995-12-28 1999-11-02 Napp Technologies, Inc. Process to prepare dihydropyridine and derivatives thereof
CN103951608B (zh) * 2009-08-04 2016-04-27 喜德生（苏州）医药科技有限公司 尼伐地平晶型及其制备方法
CN103254122B (zh) * 2013-06-19 2015-04-22 湖南师范大学 一种心血管药物尼伐地平的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3946028A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH607848A5 (de) * 1974-06-04 1978-11-30 Bayer Ag
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
DK172182A (da) 1982-04-16
AU518206B2 (en) 1981-09-17
SE8204312L (sv) 1982-07-13
SE8204312D0 (sv) 1982-07-13
DK563377A (da) 1978-06-18
AR221887A1 (es) 1981-03-31
AT367401B (de) 1982-07-12
AU3165777A (en) 1979-06-21
JPS5948828B2 (ja) 1984-11-29
ES474233A1 (es) 1979-11-01
ES465137A1 (es) 1979-01-01
ES474234A1 (es) 1979-04-01
FR2374307A1 (fr) 1978-07-13
FR2374307B1 (de) 1981-02-13
AR221478A1 (es) 1981-02-13
CH633266A5 (en) 1982-11-30
BE861964A (fr) 1978-06-16
HU176454B (en) 1981-03-28
GB1591089A (en) 1981-06-10
JPS5395977A (en) 1978-08-22
ATA901877A (de) 1981-11-15
SE7714374L (sv) 1978-06-18
DE2756226A1 (de) 1978-06-29
NL7714066A (nl) 1978-06-20

Similar Documents

Publication Publication Date Title
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
IL51297A0 (en) Proline derivatives and related compounds pharmaceutical compositions containing the same and process for the preparation thereof
IL60937A0 (en) Opitcally active 1,4-dihydropyridine compounds,their production and pharmaceutical compositions containing them
IL55423A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL53639A0 (en) New 1,4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
IL51403A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL51402A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
JPS5390254A (en) Novel 11betaasubstituted 1*3*5*10**trienesteroid process for preparing same and pharmaceutical composition
ZA786054B (en) Novel 6-oxy-genated-3,20-dioxo-pregnane-derivatives,process for the preparation thereof,and pharmaceutical compositions containing them
IL57213A0 (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetra-hydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
IL54111A (en) 3,6-disubstituted-1,2,4-triazine-5-one-derivatives,process for their preparation and pharmaceutical compositions containing them
GR60551B (en) Pharmaceutical compositions containing heterocolloidal debrycin and process for the preparation thereof
IL52134A0 (en) Uracil derivatives process for the preparation thereof and pharmaceutical compositions containing them
DE3067174D1 (en) Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them
GB2050375B (en) 4-cyanophenyl-1,4-dihydropyridine compound processes for preparation thereof and pharmaceutical composition comprising the same
GB2004885B (en) Indolopyrones process for the preparation thereof and pharmaceutical compositions containing them
GB1549931A (en) 2,2-dimethyl-19-nor-steroids processes for preparing them and pharmaceutical compositions containing them
PT67473A (en) New 6,7-dimethoxy-1,2,3,4-tetrahydro-1-isoquinolineacetamide derivatives and a process for the preparation thereof and pharmaceutical compositions containing same
ZA763955B (en) 1,4-dihydropyridine derivatives process for preparation thereof and pharmaceutical composition of the same
IL50430A0 (en) New 2,4-diamino-5-benzylpyrimidines process for their preparation and pharmaceutical compositions containing these compounds